Karin Jooss, Director at FATE THERAPEUTICS INC (FATE), sold 1,483 shares at $22.82 ($34K) on 2022-06-03, disclosed to the SEC on 2022-06-06.
Open-market sale of $34k FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.